Cetera Investment Advisers
DFTX

Cetera Investment Advisers’s Definium Therapeutics DFTX Stock Holding History

Cetera Investment Advisers’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$601K Buy
31,824
+15,224
+92% +$258K ﹤0.01% 3338
2025
Q4 		$222K Buy
16,600
+358
+2% +$4.43K ﹤0.01% 4167
2025
Q3 		$191K Buy
+16,242
New +$151K ﹤0.01% 4164

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cetera Investment Advisers's DFTX Position: Q1 2026 in Review

Cetera Investment Advisers increased its Definium Therapeutics (DFTX) stake by 92% in Q1 2026, buying an estimated $258K and bringing the position to 31,824 shares worth $601K. The position accounts for ﹤0.01% of the portfolio, ranked #3338.

Cetera Investment Advisers first reported a position in DFTX in Q3 2025 and has held it in 3 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Cetera Investment Advisers held 31,824 shares of Definium Therapeutics worth $601K as of Q1 2026.
  • Cetera Investment Advisers bought 15,224 Definium Therapeutics shares in Q1 2026, an estimated $258K.
  • Definium Therapeutics made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #3338 holding.
  • Cetera Investment Advisers first reported a position in Definium Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.